Annie Brion

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network

Sophie Langner-Lemercier, Caroline Houillier, Carole Soussain et al. · Neuro-Oncology · 2016 · 202 citations · Full text

Medicine, Oncology, Chemotherapy +10

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome

Bruno Royer, Stéphane Minvielle, Momar Diouf et al. · Journal of Clinical Oncology · 2016 · 107 citations

Medicine, Hematology, Oncology +16

TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH METHYLPREDNISOLONE AND CYCLOSPORINE WITH OR WITHOUT AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY

JEAN YVES CAHN, PIERRE BORDIGONI, Pierre Tiberghien et al. · Transplantation · 1995 · 40 citations

Life Sciences, Immunology, Pharmacotherapy +12

A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial

Gaëlle Olivier, Aline Clavert, Laurence Lacotte‐Thierry et al. · American Journal of Hematology · 2014 · 27 citations · Full text

Medicine, Oncology, Pharmacology +11

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Rémi Letestu, Abdelmalek Dahmani, Marouane Boubaya et al. · Leukemia · 2020 · 26 citations · Full text

Medicine, Clinical Sciences, Oncology +17